WO2016129100A1 - Agent for increasing useful bacteria in animal intestines, and method for improving intestinal environment in livestock in which said agent is used - Google Patents

Agent for increasing useful bacteria in animal intestines, and method for improving intestinal environment in livestock in which said agent is used Download PDF

Info

Publication number
WO2016129100A1
WO2016129100A1 PCT/JP2015/053961 JP2015053961W WO2016129100A1 WO 2016129100 A1 WO2016129100 A1 WO 2016129100A1 JP 2015053961 W JP2015053961 W JP 2015053961W WO 2016129100 A1 WO2016129100 A1 WO 2016129100A1
Authority
WO
WIPO (PCT)
Prior art keywords
livestock
bacteria
useful bacteria
agent
feed
Prior art date
Application number
PCT/JP2015/053961
Other languages
French (fr)
Japanese (ja)
Inventor
山田 豊
松井 宏樹
Original Assignee
油化産業株式会社
国立大学法人三重大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 油化産業株式会社, 国立大学法人三重大学 filed Critical 油化産業株式会社
Priority to PCT/JP2015/053961 priority Critical patent/WO2016129100A1/en
Priority to JP2016574594A priority patent/JP6557686B2/en
Priority to KR1020177018724A priority patent/KR102376381B1/en
Publication of WO2016129100A1 publication Critical patent/WO2016129100A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/70Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry

Definitions

  • the present invention relates to an agent for increasing useful intestinal bacteria that increases useful bacteria present in the intestines of animals.
  • the present invention improves the intestinal environment of livestock by increasing useful bacteria in the intestinal flora of livestock and decreasing harmful bacteria using the animal intestinal useful bacteria increasing agent of the present invention. Therefore, the present invention also relates to a method for improving the intestinal environment of livestock, which improves and maintains digestive physiological functions and immune functions, prevents the occurrence of diseases, and improves the efficient productivity of livestock.
  • the “animal” in the present invention is a vertebrate such as mammals, birds, reptiles, amphibians, fish, and the like, for example, humans, domestic animals, primates (monkeys, chimpanzees, etc.), laboratory animals (mouse, rats, etc.), etc. is there.
  • the term “livestock” in the present invention refers to industrial animals, pets, pets for viewing, and sporting animals that are accustomed or raised for human use of their products (milk, meat, eggs, etc.). There are, for example, cows, pigs, sheep, goats, horses, poultry, dogs, cats, small birds, fish farms and the like.
  • the intestinal flora includes useful and harmful bacteria.
  • useful bacteria include bacteria belonging to the genus Lactobacillus ⁇ and Bifidobacterium ⁇ . And the like. The balance of competitive growth between these useful bacteria and harmful bacteria is disrupted, resulting in an enteric bacterial flora that predominates harmful bacteria, causing a decline in immune function and digestive physiology. It is thought to lead to a decrease in productivity.
  • Patent Document 1 a nutritional supplement for livestock containing higher fatty acid triglycerides and medium chain fatty acid triglycerides
  • Patent Document 2 Dairy substitute milk composition for the purpose of improving soft stool and reducing stress
  • Patent Document 3 A milk replacer composition
  • Patent Document 4 a medium containing a medium chain fatty acid mixture
  • Patent Document 4 a pharmaceutical for inhibiting contamination by E. coli have been reported.
  • JP-A-6-153812 Japanese Patent Laid-Open No. 10-127232 Japanese Patent No. 2723961 Japanese Patent No. 5259905
  • the present invention aims at improving the intestinal environment of animals such as livestock, preventing the occurrence of diseases, and improving the productivity of livestock, paying attention to the above series of matters.
  • the present inventors have increased useful bacteria among intestinal flora of animals such as livestock, and reduced harmful bacteria. As a result, it has been found that the intestinal environment can be improved, and the occurrence of diseases and reduction in productivity can be prevented, and the present invention has been completed.
  • the present invention is an animal intestinal useful bacteria increasing agent containing at least one fatty acid selected from the group consisting of caprylic acid, capric acid and lauric acid or a salt thereof. Further, the present invention is a method for improving the intestinal environment of livestock, characterized in that a feed containing 0.1 to 2% by weight of the animal enteric useful bacteria increasing agent of the present invention is fed to livestock.
  • the animal intestinal useful bacteria increasing agent of the present invention increases the useful bacteria among the intestinal bacterial flora of animals such as livestock, and lowers harmful bacteria to make the animal's intestinal environment a dominant bacterial flora predominantly useful bacteria.
  • caprylic acid, capric acid, and lauric acid which are the main components, are essentially substances that have extremely high absorption rates and metabolic rates, and are also effective in that vitality can be obtained quickly by ingestion.
  • the method for improving the intestinal environment of livestock of the present invention can improve the intestinal environment of livestock, prevent the occurrence of diseases, and improve the productivity.
  • the animal intestinal useful bacteria increasing agent of the present invention is at least one fatty acid selected from the group consisting of caprylic acid, capric acid and lauric acid, or a salt thereof (hereinafter referred to as “the useful bacteria increasing agent”). , Also referred to as “fatty acid etc.”). It is preferable to contain two types of fatty acids or salts selected from the group consisting of caprylic acid, capric acid and lauric acid, and it is particularly preferable to contain these three types of fatty acids or salts.
  • fatty acid salt calcium salts and magnesium salts of the above-mentioned various fatty acids are preferable because they are essential mineral components for livestock, and these may be used singly or in combination of two.
  • These fatty acid metal salts are solid at room temperature, and are easy to handle and mix with feed, and in view of their effects on ruminant rumen, these fatty acid metal salts are included in lipids. Is preferred. In particular, it is more preferable to use solid powder or granular fatty acid calcium or fatty acid magnesium.
  • the useful bacteria increasing agent of the present invention can be applied to livestock such as cattle, pigs, chickens, etc., for example, short-term breeding with high breeding density (head or feather / area), switching to feed with different nutrition and form, heat, Diseases can be prevented by reducing harmful bacteria in the intestines and increasing useful bacteria during periods of various management stresses such as cold, weaning, group movements based on people in the farm, and long-distance transportation of livestock. It is possible to prevent this, maintain feed intake and promote growth, and maintain productivity.
  • Harmful bacteria that can be reduced by feeding livestock feed containing the useful bacteria increasing agent of the present invention include, for example, Escherichia Coli, Salmonella genus, Clostridium perfingers, etc. In particular, it has a strong effect on Escherichia Coli and Clostridium f perfingers.
  • useful bacteria that can be increased by feeding the animal feed of the present invention include bacteria belonging to the genus Lactobacillus genus and Bifidobacterium genus.
  • the useful bacteria increasing agent of the present invention may contain known additives such as carriers and excipients.
  • the content of the fatty acid or the like in the useful bacterium increasing agent of the present invention is preferably 70% by weight or more, particularly preferably 90% by weight or more, and further preferably 95% by weight or more. If the content is less than 70% by weight, it may be insufficient for improving the intestinal flora of animals, and other components such as long chain fatty acids and minerals will be fed, which is inefficient.
  • the useful bacteria increasing agent and livestock feed of the present invention can be used as food additives, pharmaceuticals, and also as livestock feed additives.
  • Livestock feed may contain, for example, corn flour, rice flour, flour such as rice bran, minerals, amino acids, proteins, vitamins, lipids and the like.
  • it may contain ingredients described in the Japan Standard Feed Ingredients Table (2009 edition, edited by the National Agriculture and Food Research Organization).
  • the form of the useful bacteria increasing agent and livestock feed of the present invention may be any form such as liquid, paste, powder, granule, pellet, etc., and can be prepared by a known method according to the desired form. it can.
  • the useful bacterium increasing agent of the present invention is 0.1 to 2% by weight, preferably 0.10 to 1.5% by weight, particularly preferably 0.5 to 1% by weight. It is characterized by feeding the mixed feed to livestock. If the amount of feed for livestock is less than 0.1% by weight in the feed, the effects of the present invention may not be obtained.
  • the feed frequency and the amount of feed containing the useful bacteria increasing agent of the present invention vary depending on the physical properties of the feed, the type of livestock and the body weight (age), etc., and the normal feed frequency and amount of the feed are adopted. can do.
  • caprylic acid Ca As the livestock feed used in the examples, four types of livestock feeds of caprylic acid Ca, capric acid Ca, lauric acid Ca, caprylic acid / capric acid / lauric acid mixed fatty acid Ca were prepared.
  • the fatty acid content of livestock feed is shown in Table 1.
  • Examples 1 to 5, Comparative Examples 1 to 5 The feed for livestock shown in Tables 3 and 4 was fed for 3 weeks using 50 Holstein milking cows fed with water and the basic feed shown in Table 2 for each Example and Comparative Example. Feces were sampled 3 weeks after feeding and stored frozen until analysis. Fecal bacteria counts were investigated for Bifidobacterium, Escherichia coli, Salmonella, Campylobacter jejumi, and Clostridium perfringens by real-time PCR. Specifically, the number of bacteria is determined by the procedure of 1) extracting DNA from the sample, 2) analyzing the DNA using each PCR method, and 3) quantifying the number of bacteria based on the proportional relationship between the gene amount and the number of bacteria. Asked.
  • Examples 6 to 10, Comparative Examples 6 to 10 Using 50 LWD castrated pigs fed with water and the basic feed shown in Table 11 for each of the Examples and Comparative Examples, the livestock feed shown in Tables 12 and 13 was fed for 2 weeks. did. Feces were sampled 2 weeks after feeding and stored frozen until analysis. The number of bacteria in the feces was determined by real-time PCR using the genera Bifidobacterium, Escherichia coli, Salmonella, Campylobacter jejumi., Clostridium perfringens. Was investigated.
  • the number of bacteria is determined by the procedure of 1) extracting DNA from the sample, 2) analyzing the DNA using each PCR method, and 3) quantifying the number of bacteria based on the proportional relationship between the gene amount and the number of bacteria. Asked. Then, it was calculated as a relative value with the number of swine bacteria before feeding as 1.
  • nine kinds of bacteria belonging to the genus Lactobacillus in stool that is, Lactobacillus acidophilus, Lactobacillus casei-group, Lactobacillus delbrueckii, Lactobacillus gasseri, Lactobacillus plantarum, Lactobacillus rhamnosus, and Lactobacillus reuteri were detected by multiplex PCR.
  • the feed efficiency was calculated from the incidence of diarrhea during the feeding period, the feed intake and the body weight for 2 weeks of feeding.
  • the results of each example are shown in Table 14, Table 16, Table 18, and Table 19, and the results of each comparative example are shown in Table 15, Table 17, Table 18, and Table 19, respectively.
  • the fecal Bifidobacterium genus increased 1.16 to 1.35 times, Escherichia coli 0.79 to 0.26 times, and Salmonella genus 0. It decreased from 84 times to 0.21 times, Campylobacter jejumi from 0.88 times to 0.60 times, and Clostridium pefringens from 0.89 times to 0.66 times.
  • the Biffidobacterium genus was not significantly changed from 0.93 to 1.00 times, and Escherichia Coli was from 1.00 times to 1.11 times. Salmonella genus increased 1.05 to 1.16 times, Campylobacter jejumi 1.15 to 1.27 times, and Clostridium perfringens 1.08 to 1.29 times.
  • the ratio (detection rate) of the number of Lactobacillus species in the feces of Examples 6 to 10 was 40% to 60% for L. acidophilus, 20% to 80% for L. delbrueckii, and L. delbrueckii. Gasseri was 60% to 80%, and L. rhamnosus was 40% to 60%.
  • L. acidophilus was 0% to 20%
  • L. delbrueckii was 0% to 20%
  • L. gasseri was 0% to 20%
  • the detection rate was as low as 0% to 20%, and other bacteria were not detected.
  • Example 11 to 15, Comparative Examples 11 to 15 Feeding the livestock feeds shown in Table 21 and Table 22 for 5 weeks using 100 three-week-old broiler chickens fed with water and the basic feed shown in Table 20 for each Example and Comparative Example did. Feces were sampled from 5 birds in each ward 2 weeks after feeding and stored frozen until analysis. Fecal bacteria count was investigated for Bifidobacterium genus, Escherichia coli, Salmonella genus, Campylobacter jejumi., And Clostridium perfringens by real-time PCR.
  • the number of bacteria is determined by the procedure of 1) extracting DNA from the sample, 2) analyzing the DNA using each PCR method, and 3) quantifying the number of bacteria based on the proportional relationship between the gene amount and the number of bacteria. Asked. And it calculated as a relative value by setting the number of broiler bacteria before feeding to 1.
  • nine kinds of bacteria belonging to the genus Lactobacillus in stool that is, Lactobacillus acidophilus, Lactobacillus casei-group, Lactobacillus delbrueckii, Lactobacillus gasseri, Lactobacillus plantarum, Lactobacillus rhamnosus, and Lactobacillus reuteri were detected by multiplex PCR.
  • the growth rate after 5 weeks of salary was investigated.
  • the results of each example are shown in Table 23, Table 25, and Table 27, and the results of each comparative example are shown in Table 24, Table 26, and Table 27, respectively.
  • the ratio (detection rate) of the number of detected genus Lactobacillus in Examples 11 to 15 was 40% to 60% for L. acidophilus, 40% to 60% for L. delbrueckii, and L Gasseri was detected from 40% to 80% and L. rhamnosus was detected from 40% to 80%.
  • L. delbrueckii was 0% to 20%
  • L. gasseri was 0% to 20%
  • the detection rate was low, and other bacteria were detected. There wasn't.
  • the growth rate of Examples 11 to 15 was 99 to 100%. In contrast, in Comparative Examples 11 to 15, the growth rate was 95 to 97%, which was lower than those in Examples 11 to 15.
  • the animal intestinal useful bacteria increasing agent of the present invention can improve the intestinal environment of the animal by increasing useful bacteria existing in the intestine of the animal and reducing harmful bacteria. It can be used as a pharmaceutical or as an additive for livestock feed. In particular, by feeding a livestock feed containing a specific amount of the animal intestinal useful bacteria increasing agent of the present invention, increasing the useful bacteria in the intestinal flora of livestock and reducing harmful bacteria It is possible to improve the intestinal environment of livestock, thereby preventing the occurrence of diseases and improving the productivity of livestock.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The purpose of the present invention is to improve the intestinal environment in animals such as livestock, and thereby prevent disease before it occurs, and to improve livestock productivity. This agent for increasing useful bacteria in animal intestines contains at least one fatty acid selected from the group consisting of caprylic acid, capric acid, and lauric acid, or salts thereof.

Description

動物腸内有用菌増加剤及びこれを用いた家畜腸内環境改善方法Animal intestinal useful bacteria increasing agent and livestock intestinal environment improving method using the same
 本発明は動物の腸内に存在する有用菌を増加させる動物腸内有用菌増加剤に関する。また、本発明は、本発明の動物腸内有用菌増加剤を用いて、家畜が有する腸内細菌叢のうち有用菌を増加させ、かつ有害菌を減少させることで家畜の腸内環境を改善させ、もって消化生理機能や免疫機能の改善と維持を図り、疾病の発生を未然に防ぎ、家畜の効率的生産性を改善させる家畜腸内環境改善方法にも関する。
 本発明における「動物」とは、哺乳類、鳥類、爬虫類、両生類、魚類などの脊椎動物であり、例えば、ヒト、家畜、霊長類(サル、チンパンジーなど)、実験動物(マウス、ラットなど)などである。また、本発明における「家畜」とは、人がその生産物(乳、肉、卵など)を利用するために馴致ないし飼育している産業動物、ペットや鑑賞用の愛玩動物、競技用動物であり、例えば、牛、豚、緬羊、山羊、馬、家禽、犬、猫、小鳥、養魚などが含まれる。
The present invention relates to an agent for increasing useful intestinal bacteria that increases useful bacteria present in the intestines of animals. In addition, the present invention improves the intestinal environment of livestock by increasing useful bacteria in the intestinal flora of livestock and decreasing harmful bacteria using the animal intestinal useful bacteria increasing agent of the present invention. Therefore, the present invention also relates to a method for improving the intestinal environment of livestock, which improves and maintains digestive physiological functions and immune functions, prevents the occurrence of diseases, and improves the efficient productivity of livestock.
The “animal” in the present invention is a vertebrate such as mammals, birds, reptiles, amphibians, fish, and the like, for example, humans, domestic animals, primates (monkeys, chimpanzees, etc.), laboratory animals (mouse, rats, etc.), etc. is there. The term “livestock” in the present invention refers to industrial animals, pets, pets for viewing, and sporting animals that are accustomed or raised for human use of their products (milk, meat, eggs, etc.). There are, for example, cows, pigs, sheep, goats, horses, poultry, dogs, cats, small birds, fish farms and the like.
 近年、家畜は、大規模飼育形態が一層進み、個体ではなく群管理が余儀なくされている。その現状において高飼育密度(頭又は羽/面積)による短期間飼育や、栄養や形態の異なる飼料への切り替え、暑熱、寒冷、離乳、飼育場での人本位による群移動、家畜の長距離輸送などの様々な管理ストレスにさらされるようになっている。とくに夏季には、地球温暖化によるこれまでに無い気温上昇によって家畜が受けるストレスは著しく増大し、一方で寒冷期におけるストレスについても変わらず、これら要因が家畜に与えるマイナスの影響は増す一方である。その結果、疾病の発生や成長(増体)の低下などの生産性低下、および生産物の品質への影響が大きな問題となっている。 In recent years, large-scale breeding of livestock has progressed further and forced to manage groups rather than individuals. In the current situation, short-term breeding with high breeding density (head or wings / area), switching to feeds with different nutrition and forms, heat, cold, weaning, group movements based on people in the breeding ground, long-distance transportation of livestock It has come to be exposed to various management stress such as. Especially in the summer, the stress experienced by livestock is significantly increased due to unprecedented temperature rise due to global warming, while the stress during the cold season remains unchanged, and the negative impact of these factors on livestock is increasing. . As a result, productivity degradation such as the occurrence of diseases and a decrease in growth (gain), and the effect on the quality of products have become major problems.
 ストレスが家畜の生産性を低下させる間接的要因として、消化管等の内臓が虚弱化し、飼料摂取量の低下または栄養成分の消化と吸収を著しく低下、腸内細菌叢の撹乱や免疫力の低下によって、細菌や原虫などの病原体に感染しやすくなることが挙げられる。腸内細菌叢には有用菌と有害菌が含まれ、有用菌としてLactobacillus 属やBifidobacterium 属に属する菌などが挙げられ、一方で有害菌としてEscherichia Coli、Salmonella属に属する菌、Campylobacter jejuni、Clostridium perfingers等の菌が挙げられる。これら有用菌と有害菌との競争的な増殖のバランスが崩れて有害菌優勢の腸内細菌叢となることで、免疫機能の低下や消化生理機能の低下を引き起こし、結果的に疾病の発生や生産性の低下につながると考えられている。 As an indirect factor that reduces livestock productivity, stress weakens the internal organs of the digestive tract, significantly lowers food intake or digestion and absorption of nutrients, disrupts the gut microbiota and decreases immunity This makes it easier to infect pathogens such as bacteria and protozoa. The intestinal flora includes useful and harmful bacteria. Examples of useful bacteria include bacteria belonging to the genus Lactobacillus や and Bifidobacterium 、. And the like. The balance of competitive growth between these useful bacteria and harmful bacteria is disrupted, resulting in an enteric bacterial flora that predominates harmful bacteria, causing a decline in immune function and digestive physiology. It is thought to lead to a decrease in productivity.
 ストレスを受けた家畜への対処法として、例えば、高級脂肪酸トリグリセライドと中鎖脂肪酸トリグリセライドを含有する家畜用栄養補給剤(特許文献1)、動植物性油脂と食物繊維を含有し、幼畜の下痢・軟便の改善及びストレスの軽減を目的とする幼畜用代用乳組成物(特許文献2)、主成分として脱脂粉乳及び/又は大豆ミールを含み、かつ中鎖脂肪酸又はその塩を含有する子畜用代用乳組成物(特許文献3)、中鎖脂肪酸混合物を含み、大腸菌による汚染等を阻害するための医薬(特許文献4)などが報告されている。 As a method for dealing with stressed livestock, for example, it contains a nutritional supplement for livestock containing higher fatty acid triglycerides and medium chain fatty acid triglycerides (Patent Document 1), animal and vegetable oils and dietary fiber, Dairy substitute milk composition for the purpose of improving soft stool and reducing stress (Patent Document 2), containing non-fat dry milk and / or soybean meal as a main component, and containing a medium chain fatty acid or a salt thereof A milk replacer composition (Patent Document 3), a medium containing a medium chain fatty acid mixture, and a pharmaceutical (Patent Document 4) for inhibiting contamination by E. coli have been reported.
特開平6-153812号公報JP-A-6-153812 特開平10-127232号公報Japanese Patent Laid-Open No. 10-127232 特許第2723961号公報Japanese Patent No. 2723961 特許第5259905号公報Japanese Patent No. 5259905
 しかしながら、高級脂肪酸トリグリセライドと中鎖脂肪酸トリグリセライドの補給だけ、または食物繊維との併用だけでは、家畜の活力が向上するまでに時間を要するので、病原体が感染する時間的余裕ができてしまい、生産性低下の改善が困難となってしまう。その上、栄養的、飼養管理的及び飼育環境的ストレスによって生じる生体調整機能や免疫機能の低下を改善すると共に、腸管粘膜、とくに絨毛などを修復しなければ、十分な成長、飼料効率などの生産性の改善や下痢などの疾病発生の改善は望めないなどの問題点がある。また、中鎖脂肪酸の混合物についても栄養補給効果や腸内大腸菌の抑制効果はあるが、他の有害菌の抑制やビフィズス菌などの有用菌に与える影響については知られていない。 However, only supplementation with higher fatty acid triglycerides and medium-chain fatty acid triglycerides, or combination with dietary fiber, requires time until livestock vitality is improved, so there is time to infect pathogens and productivity. It becomes difficult to improve the decrease. In addition, the improvement of the biological regulation function and immune function caused by nutritional, rearing management and rearing environmental stress is improved, and if the intestinal mucosa, especially the villus, is not restored, production such as sufficient growth and feed efficiency is achieved. There are problems such as improvement of sex and improvement of diseases such as diarrhea. In addition, a medium-chain fatty acid mixture also has a nutritional supplementation effect and an intestinal Escherichia coli inhibitory effect, but the effects on other harmful bacteria and useful bacteria such as bifidobacteria are not known.
 本発明は、上記の一連の事柄に着目し、家畜等の動物の腸内環境を改善させ、もって疾病の発生を未然に防ぎ、家畜の生産性を向上させることを目的とする。 The present invention aims at improving the intestinal environment of animals such as livestock, preventing the occurrence of diseases, and improving the productivity of livestock, paying attention to the above series of matters.
 本発明者らは、上記課題を解決するために鋭意検討を行った結果、特定の酸又はその塩が家畜等の動物が有する腸内細菌叢のうち有用菌を増加させ、かつ有害菌を低下させることで腸内環境を改善させ、疾病の発生や生産性低下を防ぐことができることを見出し、本発明を完成させるに至った。 As a result of intensive studies to solve the above-mentioned problems, the present inventors have increased useful bacteria among intestinal flora of animals such as livestock, and reduced harmful bacteria. As a result, it has been found that the intestinal environment can be improved, and the occurrence of diseases and reduction in productivity can be prevented, and the present invention has been completed.
 すなわち本発明は、カプリル酸、カプリン酸及びラウリン酸からなる群から選ばれる少なくとも1種類の脂肪酸又はその塩を含有する動物腸内有用菌増加剤である。
 また本発明は、本発明の動物腸内有用菌増加剤が0.1~2重量%配合された飼料を家畜に給与することを特徴とする家畜腸内環境改善方法である。
That is, the present invention is an animal intestinal useful bacteria increasing agent containing at least one fatty acid selected from the group consisting of caprylic acid, capric acid and lauric acid or a salt thereof.
Further, the present invention is a method for improving the intestinal environment of livestock, characterized in that a feed containing 0.1 to 2% by weight of the animal enteric useful bacteria increasing agent of the present invention is fed to livestock.
 動物の腸管内には多数の細菌群が存在し腸内細菌叢を形成している。本発明の動物腸内有用菌増加剤は、家畜等の動物が有する腸内細菌叢のうち有用菌を増加させ、かつ有害菌を低下させて、動物の腸内環境を有用菌優勢の細菌叢へ改善し、疾病の発生を未然に防ぎ、生産性を向上させることができる。その上、主成分であるカプリル酸、カプリン酸及びラウリン酸は、本来吸収速度と代謝速度が極めて速い物質であり、摂取することで活力がすばやく得られるという点でも有効である。
 また、本発明の家畜腸内環境改善方法は、家畜の腸内環境を改善し、疾病の発生を未然に防ぎ、生産性を向上させることができる。
A large number of bacterial groups exist in the intestinal tract of animals to form an intestinal flora. The animal intestinal useful bacteria increasing agent of the present invention increases the useful bacteria among the intestinal bacterial flora of animals such as livestock, and lowers harmful bacteria to make the animal's intestinal environment a dominant bacterial flora predominantly useful bacteria. Can improve the productivity, prevent the occurrence of diseases, and improve the productivity. In addition, caprylic acid, capric acid, and lauric acid, which are the main components, are essentially substances that have extremely high absorption rates and metabolic rates, and are also effective in that vitality can be obtained quickly by ingestion.
Further, the method for improving the intestinal environment of livestock of the present invention can improve the intestinal environment of livestock, prevent the occurrence of diseases, and improve the productivity.
 以下、本発明について詳細に説明する。
 本発明の動物腸内有用菌増加剤(以下、単に「有用菌増加剤」ともいう。)は、カプリル酸、カプリン酸及びラウリン酸からなる群から選ばれる少なくとも1種類の脂肪酸又はその塩(以下、「脂肪酸等」ともいう。)を含有する。カプリル酸、カプリン酸及びラウリン酸からなる群から選ばれる2種類の脂肪酸又は塩を含有するのが好ましく、これら3種類の脂肪酸又は塩を含有するのが特に好ましい。
Hereinafter, the present invention will be described in detail.
The animal intestinal useful bacteria increasing agent of the present invention (hereinafter, also simply referred to as “useful bacteria increasing agent”) is at least one fatty acid selected from the group consisting of caprylic acid, capric acid and lauric acid, or a salt thereof (hereinafter referred to as “the useful bacteria increasing agent”). , Also referred to as “fatty acid etc.”). It is preferable to contain two types of fatty acids or salts selected from the group consisting of caprylic acid, capric acid and lauric acid, and it is particularly preferable to contain these three types of fatty acids or salts.
 上記脂肪酸の塩としては、家畜に対する必須ミネラル成分である点から、上記の各種脂肪酸のカルシウム塩及びマグネシウム塩が好適であり、これらは一種で用いてもよく、二種を組み合わせて用いてもよい。これら脂肪酸の金属塩は常温では固体であり、取り扱いの容易さ及び飼料に混和し易さの点で、また、反芻動物のルーメンへの影響を考慮して、脂質の中ではこれらの脂肪酸金属塩が好ましい。特に固体粉末状あるいは顆粒状の脂肪酸カルシウムや脂肪酸マグネシウムを用いることがより好ましい。 As the fatty acid salt, calcium salts and magnesium salts of the above-mentioned various fatty acids are preferable because they are essential mineral components for livestock, and these may be used singly or in combination of two. . These fatty acid metal salts are solid at room temperature, and are easy to handle and mix with feed, and in view of their effects on ruminant rumen, these fatty acid metal salts are included in lipids. Is preferred. In particular, it is more preferable to use solid powder or granular fatty acid calcium or fatty acid magnesium.
 本発明の有用菌増加剤は、牛、豚、鶏等の家畜に適用でき、例えば高飼育密度(頭又は羽/面積)による短期間飼育や、栄養や形態の異なる飼料への切り替え、暑熱、寒冷、離乳、飼育場での人本位による群移動、家畜の長距離輸送などの様々な管理ストレスを受ける時期において、腸内の有害菌を減少させ、有用菌を増加させることで、疾病を未然に防ぎ、飼料摂取量の維持や成長を促進させ、生産性を維持することができる。 The useful bacteria increasing agent of the present invention can be applied to livestock such as cattle, pigs, chickens, etc., for example, short-term breeding with high breeding density (head or feather / area), switching to feed with different nutrition and form, heat, Diseases can be prevented by reducing harmful bacteria in the intestines and increasing useful bacteria during periods of various management stresses such as cold, weaning, group movements based on people in the farm, and long-distance transportation of livestock. It is possible to prevent this, maintain feed intake and promote growth, and maintain productivity.
 本発明の有用菌増加剤が配合された家畜用飼料(以下、本発明の家畜用飼料ともいう。)の給与によって減少することのできる有害菌は、例えば、Escherichia Coli、Salmonella属、Clostridium perfingers等が挙げられ、特にEscherichia Coli、Clostridium perfingersに対して強い効果を示す。また本発明の家畜用飼料の給与によって増加することのできる有用菌は、例えば、Lactobacillus 属やBifidobacterium 属に属する菌などが挙げられる。 Harmful bacteria that can be reduced by feeding livestock feed containing the useful bacteria increasing agent of the present invention (hereinafter also referred to as livestock feed of the present invention) include, for example, Escherichia Coli, Salmonella genus, Clostridium perfingers, etc. In particular, it has a strong effect on Escherichia Coli and Clostridium f perfingers. Examples of useful bacteria that can be increased by feeding the animal feed of the present invention include bacteria belonging to the genus Lactobacillus genus and Bifidobacterium genus.
 本発明の有用菌増加剤は、担体、賦形剤などの公知の添加剤を含有していてもよい。本発明の有用菌増加剤における上記の脂肪酸等の含有量は、好ましくは70重量%以上、特に好ましくは90重量%以上、更に好ましくは95重量%以上である。含有量が70重量%未満では、動物の腸内細菌叢を改善するには不十分となる場合があり、また長鎖脂肪酸やミネラル等の他成分も給与することになり、非効率である。 The useful bacteria increasing agent of the present invention may contain known additives such as carriers and excipients. The content of the fatty acid or the like in the useful bacterium increasing agent of the present invention is preferably 70% by weight or more, particularly preferably 90% by weight or more, and further preferably 95% by weight or more. If the content is less than 70% by weight, it may be insufficient for improving the intestinal flora of animals, and other components such as long chain fatty acids and minerals will be fed, which is inefficient.
  本発明の有用菌増加剤及び家畜用飼料は、食品添加剤、医薬品として、また家畜用飼料の添加剤としても使用することができる。
 家畜用飼料は、例えば、トウモロコシ粉、米粉、糠などの穀粉、無機物、アミノ酸、タンパク質、ビタミン類、脂質などを含んでいてもよい。例えば、日本標準飼料成分表(2009年版、独立行政法人 農業・ 食品産業技術総合研究機構編)に記載された成分を含んでいてもよい。
 本発明の有用菌増加剤及び家畜用飼料の形態としては、液状、ペースト状、粉状、粒状、ペレットなどいずれの形態でもよく、所望する形態に応じて、公知の方法にて調製することができる。
The useful bacteria increasing agent and livestock feed of the present invention can be used as food additives, pharmaceuticals, and also as livestock feed additives.
Livestock feed may contain, for example, corn flour, rice flour, flour such as rice bran, minerals, amino acids, proteins, vitamins, lipids and the like. For example, it may contain ingredients described in the Japan Standard Feed Ingredients Table (2009 edition, edited by the National Agriculture and Food Research Organization).
The form of the useful bacteria increasing agent and livestock feed of the present invention may be any form such as liquid, paste, powder, granule, pellet, etc., and can be prepared by a known method according to the desired form. it can.
 本発明の家畜腸内環境改善方法においては、本発明の有用菌増加剤が0.1~2重量%、好ましくは0.10~1.5重量%、特に好ましくは0.5~1重量%配合された飼料を家畜に給与することを特徴とする。家畜に対する給与量が、飼料中0.1重量%未満では本発明の効果が得られないことがある。
 なお、本発明の有用菌増加剤が配合された飼料の給与頻度や給与量は、飼料の物性、家畜の種類や体重(年齢)などにより異なり、当該飼料の通常の給与頻度や給与量を採用することができる。
In the livestock intestinal environment improving method of the present invention, the useful bacterium increasing agent of the present invention is 0.1 to 2% by weight, preferably 0.10 to 1.5% by weight, particularly preferably 0.5 to 1% by weight. It is characterized by feeding the mixed feed to livestock. If the amount of feed for livestock is less than 0.1% by weight in the feed, the effects of the present invention may not be obtained.
In addition, the feed frequency and the amount of feed containing the useful bacteria increasing agent of the present invention vary depending on the physical properties of the feed, the type of livestock and the body weight (age), etc., and the normal feed frequency and amount of the feed are adopted. can do.
 以下、実施例により本発明を更に詳細に説明するが、本発明はその要旨を超えない限りこれらに限定されない。  Hereinafter, the present invention will be described in more detail by way of examples, but the present invention is not limited to these unless it exceeds the gist. *
 実施例に使用する家畜用飼料として、カプリル酸Ca、カプリン酸Ca、ラウリン酸Ca、カプリル酸・カプリン酸・ラウリン酸混合脂肪酸Caの4種類の家畜用飼料を用意した。なお、「カプリル酸・カプリン酸・ラウリン酸混合脂肪酸Ca」は、カプリル酸:カプリン酸:ラウリン酸=20:20:60(重量比)からなる混合脂肪酸のカルシウム塩であり、油化産業株式会社製の商品である。家畜用飼料の脂肪酸含有率を表1に示す。 As the livestock feed used in the examples, four types of livestock feeds of caprylic acid Ca, capric acid Ca, lauric acid Ca, caprylic acid / capric acid / lauric acid mixed fatty acid Ca were prepared. “Caprylic acid / capric acid / lauric acid mixed fatty acid Ca” is a calcium salt of a mixed fatty acid composed of caprylic acid: capric acid: lauric acid = 20: 20: 60 (weight ratio). It is a made product. The fatty acid content of livestock feed is shown in Table 1.
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
 〔実施例1~5、比較例1~5〕
 水および表2に示した基礎飼料を飽食給与しているホルスタイン搾乳牛50頭を実施例及び比較例ごとに5頭用いて、表3及び表4に示した家畜用飼料を3週間給与した。給与3週間後に糞をサンプリングし、分析まで凍結保存した。糞中細菌数はリアルタイムPCR法によりBifidobacterium 属、Escherichia coli 、Salmonella 属、Campylobacter jejumi. 、Clostridium perfringens について調査した。具体的には、1)検体からDNAを抽出、2)そのDNAを用いて各PCR法で分析、3)遺伝子量と細菌数との比例関係に基づき細菌数を定量、の手順によって細菌数を求めた。そして、給与する前の細菌数を1とした相対値として算出した。また、マルチプレックスPCR法により、糞便中のLactobacillus 属細菌9種類、つまりLactobacillus acidophilus 、Lactobacillus casei-group 、Lactobacillus delbrueckii 、Lactobacillus gasseri 、Lactobacillus plantarum 、Lactobacillus rhamnosus 、Lactobacillus reuteri の検出を行った。さらに給与期間中の下痢発生率、給与3週間後の乳生産量、乳脂率、乳タンパク質率を調査した。各実施例の結果を表5、表7、表9及び表10に、各比較例の結果を表6、表8、表9及び表10にそれぞれ示す。
[Examples 1 to 5, Comparative Examples 1 to 5]
The feed for livestock shown in Tables 3 and 4 was fed for 3 weeks using 50 Holstein milking cows fed with water and the basic feed shown in Table 2 for each Example and Comparative Example. Feces were sampled 3 weeks after feeding and stored frozen until analysis. Fecal bacteria counts were investigated for Bifidobacterium, Escherichia coli, Salmonella, Campylobacter jejumi, and Clostridium perfringens by real-time PCR. Specifically, the number of bacteria is determined by the procedure of 1) extracting DNA from the sample, 2) analyzing the DNA using each PCR method, and 3) quantifying the number of bacteria based on the proportional relationship between the gene amount and the number of bacteria. Asked. And it calculated as a relative value with the number of bacteria before feeding as 1. In addition, nine kinds of bacteria belonging to the genus Lactobacillus in stool, that is, Lactobacillus acidophilus, Lactobacillus casei-group, Lactobacillus delbrueckii, Lactobacillus gasseri, Lactobacillus plantarum, Lactobacillus rhamnosus, and Lactobacillus reuteri were detected by multiplex PCR. Furthermore, the incidence of diarrhea during the salary period, milk production, milk fat rate, and milk protein rate after 3 weeks of feeding were investigated. The results of each Example are shown in Table 5, Table 7, Table 9, and Table 10, and the results of each Comparative Example are shown in Table 6, Table 8, Table 9, and Table 10, respectively.
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000007
Figure JPOXMLDOC01-appb-T000007
Figure JPOXMLDOC01-appb-T000008
Figure JPOXMLDOC01-appb-T000008
Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000010
Figure JPOXMLDOC01-appb-T000010
 表5に示すように、本発明に係る実施例1~5の有用菌増加剤を給与したウシの糞中Bifidobacterium 属菌数は無給与牛の1.02倍から1.18倍に増加し、Escherichia coliは0.77倍から0.16倍に減少し、Clostridium perfringens は0.89倍~0.70倍に減少した。
 これに対し、表6に示すように、比較例1~5ではBifidobacterium 属及びEscherichia coliに大きな増減は無く、Clostridium perfringens は最大1.22倍に増加した。実施例1~5ではSalmonella属菌数が0.98倍~0.93倍と大きな変化は無く、Campylobacter jejumiが1.13倍~1.16倍とわずかに増加したのに対し、比較例1~5ではSalmonella属が1.01~1.10倍、Campylobacter jejumiが1.17~1.26倍となっており、実施例では両者の菌数の増加を抑制したことが分かる。
As shown in Table 5, the number of genus Bifidobacterium in the feces of cattle fed with the useful bacteria increasing agent of Examples 1 to 5 according to the present invention increased from 1.02 times to 1.18 times that of non-feeding cattle, Escherichia coli decreased from 0.77 times to 0.16 times, and Clostridium perfringens decreased from 0.89 times to 0.70 times.
On the other hand, as shown in Table 6, in Comparative Examples 1 to 5, there was no significant increase or decrease in Bifidobacterium genus and Escherichia coli, and Clostridium perfringens increased up to 1.22 times. In Examples 1 to 5, the number of Salmonella spp. Was not significantly changed from 0.98 times to 0.93 times, and Campylobacter jejumi was slightly increased from 1.13 times to 1.16 times, whereas Comparative Example 1 From 5 to 5, Salmonella genus was 1.01 to 1.10 times, and Campylobacter jejumi was 1.17 to 1.26 times, indicating that the increase in the number of both bacteria was suppressed in the Examples.
 表7に示すように、実施例1~5の糞中Lactobacillus 属の検出頭数の割合は、L. Casei-groupが20%~40%、L. gasseriが40%~60%であった。
 これに対して、表8に示すように、比較例1~5では何れの菌も検出された個体は無かった。
As shown in Table 7, the proportions of Lactobacillus genus detected in Examples 1 to 5 were 20% to 40% for L. Casei-group and 40% to 60% for L. gasseri.
On the other hand, as shown in Table 8, in Comparative Examples 1 to 5, no individual was detected in any bacteria.
 また、表9に示すように実施例1~5の下痢発生率は0~20%であった。
 これに対し、比較例1~5では40~80%と実施例1~5よりも下痢発生率が高かった。
As shown in Table 9, the incidence of diarrhea in Examples 1 to 5 was 0 to 20%.
On the other hand, the incidence of diarrhea was higher in Comparative Examples 1-5 than in Examples 1-5, 40-80%.
 表10に示すように実施例1~5では乳生産量が37~39kg/日と高かった。
 これに対し、比較例1~5では33~35kg/日と実施例1~5よりも乳生産量が低かった。
As shown in Table 10, in Examples 1 to 5, milk production was as high as 37 to 39 kg / day.
In contrast, in Comparative Examples 1 to 5, the milk production was 33 to 35 kg / day, which was lower than in Examples 1 to 5.
 〔実施例6~10、比較例6~10〕
 水および表11に示した基礎飼料を飽食給与しているLWD種去勢子ブタ50頭を実施例及び比較例ごとに5頭用いて、表12及び表13に示した家畜用飼料を2週間給与した。給与2週間後に糞をサンプリングし、分析まで凍結保存した。糞中細菌数はリアルタイムPCR法によりBifidobacterium 属、Escherichia coli、Salmonella属、Campylobacter jejumi. 、Clostridium perfringens
について調査した。具体的には、1)検体からDNAを抽出、2)そのDNAを用いて各PCR法で分析、3)遺伝子量と細菌数との比例関係に基づき細菌数を定量、の手順によって細菌数を求めた。そして、給与する前のブタの細菌数を1とした相対値として算出した。また、マルチプレックスPCR法により、糞便中のLactobacillus 属細菌9種類、つまりLactobacillus acidophilus 、Lactobacillus casei-group 、Lactobacillus delbrueckii 、Lactobacillus gasseri 、Lactobacillus plantarum 、Lactobacillus rhamnosus 、Lactobacillus reuteri の検出を行った。さらに給与期間中の下痢発生率と、給与2週間の飼料摂取量と体重から飼料効率を算出した。各実施例の結果を表14、表16、表18及び表19に、各比較例の結果を表15、表17、表18及び表19にそれぞれ示す。
[Examples 6 to 10, Comparative Examples 6 to 10]
Using 50 LWD castrated pigs fed with water and the basic feed shown in Table 11 for each of the Examples and Comparative Examples, the livestock feed shown in Tables 12 and 13 was fed for 2 weeks. did. Feces were sampled 2 weeks after feeding and stored frozen until analysis. The number of bacteria in the feces was determined by real-time PCR using the genera Bifidobacterium, Escherichia coli, Salmonella, Campylobacter jejumi., Clostridium perfringens.
Was investigated. Specifically, the number of bacteria is determined by the procedure of 1) extracting DNA from the sample, 2) analyzing the DNA using each PCR method, and 3) quantifying the number of bacteria based on the proportional relationship between the gene amount and the number of bacteria. Asked. Then, it was calculated as a relative value with the number of swine bacteria before feeding as 1. In addition, nine kinds of bacteria belonging to the genus Lactobacillus in stool, that is, Lactobacillus acidophilus, Lactobacillus casei-group, Lactobacillus delbrueckii, Lactobacillus gasseri, Lactobacillus plantarum, Lactobacillus rhamnosus, and Lactobacillus reuteri were detected by multiplex PCR. Furthermore, the feed efficiency was calculated from the incidence of diarrhea during the feeding period, the feed intake and the body weight for 2 weeks of feeding. The results of each example are shown in Table 14, Table 16, Table 18, and Table 19, and the results of each comparative example are shown in Table 15, Table 17, Table 18, and Table 19, respectively.
Figure JPOXMLDOC01-appb-T000011
Figure JPOXMLDOC01-appb-T000011
Figure JPOXMLDOC01-appb-T000012
Figure JPOXMLDOC01-appb-T000012
Figure JPOXMLDOC01-appb-T000013
Figure JPOXMLDOC01-appb-T000013
Figure JPOXMLDOC01-appb-T000014
Figure JPOXMLDOC01-appb-T000014
Figure JPOXMLDOC01-appb-T000015
Figure JPOXMLDOC01-appb-T000015
Figure JPOXMLDOC01-appb-T000016
Figure JPOXMLDOC01-appb-T000016
Figure JPOXMLDOC01-appb-T000017
Figure JPOXMLDOC01-appb-T000017
Figure JPOXMLDOC01-appb-T000018
Figure JPOXMLDOC01-appb-T000018
Figure JPOXMLDOC01-appb-T000019
Figure JPOXMLDOC01-appb-T000019
 表14に示すように、実施例6~10では、糞中Bifidobacterium 属が1.16倍~1.35倍に増加し、Escherichia coliが0.79倍~0.26倍、Salmonella属が0.84倍~0.21倍、Campylobacter jejumiが0.88倍~0.60倍、Clostridium pefringensが0.89倍~0.66倍に減少した。
 これに対して、表15に示すように、比較例6~10の場合、Biffidobacterium属が0.93~1.00倍と大きな変化は無く、Escherichia Coliが1.00倍~1.11倍、Salmonella属が1.05倍~1.16倍、Campylobacter jejumiが1.15~1.27倍、Clostridium perfringens が1.08~1.29倍と増加した。
As shown in Table 14, in Examples 6 to 10, the fecal Bifidobacterium genus increased 1.16 to 1.35 times, Escherichia coli 0.79 to 0.26 times, and Salmonella genus 0. It decreased from 84 times to 0.21 times, Campylobacter jejumi from 0.88 times to 0.60 times, and Clostridium pefringens from 0.89 times to 0.66 times.
On the other hand, as shown in Table 15, in Comparative Examples 6 to 10, the Biffidobacterium genus was not significantly changed from 0.93 to 1.00 times, and Escherichia Coli was from 1.00 times to 1.11 times. Salmonella genus increased 1.05 to 1.16 times, Campylobacter jejumi 1.15 to 1.27 times, and Clostridium perfringens 1.08 to 1.29 times.
 表16に示すように、実施例6~10の糞中Lactobacillus 属の検出頭数の割合(検出率)は、L. acidophilusが40%~60%、L. delbrueckiiが20%~80%、L. gasseriが60%~80%、L. rhamnosusが40%~60%であった。
 これに対し、表17に示すように、比較例6~10ではL. acidophilusが0%~20%、L. delbrueckiiで0%~20%、L. gasseriで0%~20%、L. rhamnosusで0%~20%と検出率は低く、また他の菌については検出されなかった。
As shown in Table 16, the ratio (detection rate) of the number of Lactobacillus species in the feces of Examples 6 to 10 was 40% to 60% for L. acidophilus, 20% to 80% for L. delbrueckii, and L. delbrueckii. Gasseri was 60% to 80%, and L. rhamnosus was 40% to 60%.
On the other hand, as shown in Table 17, in Comparative Examples 6 to 10, L. acidophilus was 0% to 20%, L. delbrueckii was 0% to 20%, L. gasseri was 0% to 20%, L. rhamnosus The detection rate was as low as 0% to 20%, and other bacteria were not detected.
 また、表18に示すように実施例6~10の下痢発生率は0~20%であった。
 これに対し、比較例6~10では40~80%と実施例6~10よりも下痢発生率が高かった。
As shown in Table 18, the incidence of diarrhea in Examples 6 to 10 was 0 to 20%.
On the other hand, the incidence of diarrhea was higher in Comparative Examples 6 to 10 than in Examples 6 to 10, which was 40 to 80%.
 また、表19に示すように実施例6~10の飼料効率は0.81~0.84と高かった。
 これに対し、比較例6~10では0.77から0.79と実施例6~10よりも飼料効率が低かった。
As shown in Table 19, the feed efficiency of Examples 6 to 10 was as high as 0.81 to 0.84.
On the other hand, in Comparative Examples 6 to 10, the feed efficiency was 0.77 to 0.79, which was lower than that of Examples 6 to 10.
 〔実施例11~15、比較例11~15〕
 水および表20に示した基礎飼料を飽食給与している3週齢のブロイラー1000羽を実施例及び比較例ごとに100羽用いて、表21及び表22に示した家畜用飼料を5週間給与した。給与2週間後に各区5羽ずつから糞をサンプリングし、分析まで凍結保存した。糞中細菌数はリアルタイムPCR法によりBifidobacterium 属、Escherichia coli、Salmonella属、Campylobacter jejumi. 、Clostridium perfringens について調査した。具体的には、1)検体からDNAを抽出、2)そのDNAを用いて各PCR法で分析、3)遺伝子量と細菌数との比例関係に基づき細菌数を定量、の手順によって細菌数を求めた。そして、給与する前のブロイラーの細菌数を1とした相対値として算出した。また、マルチプレックスPCR法により、糞便中のLactobacillus 属細菌9種類、つまりLactobacillus acidophilus 、Lactobacillus casei-group 、Lactobacillus delbrueckii 、Lactobacillus gasseri 、Lactobacillus plantarum 、Lactobacillus rhamnosus 、Lactobacillus reuteri の検出を行った。また、給与5週間後の育成率を調査した。各実施例の結果を表23、表25及び表27に、各比較例の結果を表24、表26及び表27にそれぞれ示す。
[Examples 11 to 15, Comparative Examples 11 to 15]
Feeding the livestock feeds shown in Table 21 and Table 22 for 5 weeks using 100 three-week-old broiler chickens fed with water and the basic feed shown in Table 20 for each Example and Comparative Example did. Feces were sampled from 5 birds in each ward 2 weeks after feeding and stored frozen until analysis. Fecal bacteria count was investigated for Bifidobacterium genus, Escherichia coli, Salmonella genus, Campylobacter jejumi., And Clostridium perfringens by real-time PCR. Specifically, the number of bacteria is determined by the procedure of 1) extracting DNA from the sample, 2) analyzing the DNA using each PCR method, and 3) quantifying the number of bacteria based on the proportional relationship between the gene amount and the number of bacteria. Asked. And it calculated as a relative value by setting the number of broiler bacteria before feeding to 1. In addition, nine kinds of bacteria belonging to the genus Lactobacillus in stool, that is, Lactobacillus acidophilus, Lactobacillus casei-group, Lactobacillus delbrueckii, Lactobacillus gasseri, Lactobacillus plantarum, Lactobacillus rhamnosus, and Lactobacillus reuteri were detected by multiplex PCR. In addition, the growth rate after 5 weeks of salary was investigated. The results of each example are shown in Table 23, Table 25, and Table 27, and the results of each comparative example are shown in Table 24, Table 26, and Table 27, respectively.
Figure JPOXMLDOC01-appb-T000020
Figure JPOXMLDOC01-appb-T000020
Figure JPOXMLDOC01-appb-T000021
Figure JPOXMLDOC01-appb-T000021
Figure JPOXMLDOC01-appb-T000022
Figure JPOXMLDOC01-appb-T000022
Figure JPOXMLDOC01-appb-T000023
Figure JPOXMLDOC01-appb-T000023
Figure JPOXMLDOC01-appb-T000024
Figure JPOXMLDOC01-appb-T000024
Figure JPOXMLDOC01-appb-T000025
Figure JPOXMLDOC01-appb-T000025
Figure JPOXMLDOC01-appb-T000026
Figure JPOXMLDOC01-appb-T000026
Figure JPOXMLDOC01-appb-T000027
Figure JPOXMLDOC01-appb-T000027
 表23に示すように、実施例11~15では、糞中Bifidobacterium 属が1.16倍~1.31倍に増加し、Escherichia coliが0.77倍~0.40倍、Salmonella属が0.68倍~0.23倍、Campylobacter jejumiが0.80倍~0.63倍、Clostridium pefringensが0.85倍~0.64倍に減少した。
 これに対して、表24に示すように、比較例11~15の場合、Biffidobacterium属が0.98~1.01倍と大きな変化は無く、Escherichia Coliが0.99倍~1.11倍、Salmonella属が1.04倍~1.11倍、Campylobacter jejumiが1.00~1.16倍、Clostridium perfringens が0.99~1.10倍と大きな変化が無いか、又は増加した。
As shown in Table 23, in Examples 11 to 15, the fecal Bifidobacterium genus increased 1.16 to 1.31 times, Escherichia coli 0.77 to 0.40 times, and Salmonella genus 0. 68 times to 0.23 times, Campylobacter jejumi decreased to 0.80 times to 0.63 times, and Clostridium pefringens decreased to 0.85 times to 0.64 times.
On the other hand, as shown in Table 24, in the case of Comparative Examples 11 to 15, the Biffidobacterium genus was not significantly changed from 0.98 to 1.01 times, and Escherichia Coli was from 0.99 times to 1.11 times. Salmonella genus was 1.04 to 1.11 times, Campylobacter jejumi was 1.00 to 1.16 times, and Clostridium perfringens was 0.99 to 1.10 times.
 表25に示すように、実施例11~15の糞中Lactobacillus 属の検出羽数の割合(検出率)は、L. acidophilusが40%~60%、L. delbrueckiiが40%~60%、L. gasseriが40%~80%、L. rhamnosusが40%~80%検出された。
 これに対し、表26に示すように、比較例11~15ではL. delbrueckiiが0%~20%、L. gasseriで0%~20%と検出率は低く、また他の菌については検出されなかった。
As shown in Table 25, the ratio (detection rate) of the number of detected genus Lactobacillus in Examples 11 to 15 was 40% to 60% for L. acidophilus, 40% to 60% for L. delbrueckii, and L Gasseri was detected from 40% to 80% and L. rhamnosus was detected from 40% to 80%.
On the other hand, as shown in Table 26, in Comparative Examples 11 to 15, L. delbrueckii was 0% to 20%, L. gasseri was 0% to 20%, and the detection rate was low, and other bacteria were detected. There wasn't.
 また、表27に示すように実施例11~15の育成率は99~100%であった。
 これに対し比較例11~15では95~97%と実施例11~15よりも育成率が低かった。
As shown in Table 27, the growth rate of Examples 11 to 15 was 99 to 100%.
In contrast, in Comparative Examples 11 to 15, the growth rate was 95 to 97%, which was lower than those in Examples 11 to 15.
 本発明の動物腸内有用菌増加剤は、動物の腸内に存在する有用菌を増加させ、かつ有害菌を減少させることで動物の腸内環境を改善させることができるので、食品添加剤、医薬品として、また家畜用飼料の添加剤としても使用することができる。特に、本発明の動物腸内有用菌増加剤が特定量配合された飼料を家畜に給与することによって、家畜が有する腸内細菌叢のうち有用菌を増加させ、かつ有害菌を減少させることで家畜の腸内環境を改善させ、もって疾病の発生を未然に防ぎ、家畜の生産性を向上させることができる。 The animal intestinal useful bacteria increasing agent of the present invention can improve the intestinal environment of the animal by increasing useful bacteria existing in the intestine of the animal and reducing harmful bacteria. It can be used as a pharmaceutical or as an additive for livestock feed. In particular, by feeding a livestock feed containing a specific amount of the animal intestinal useful bacteria increasing agent of the present invention, increasing the useful bacteria in the intestinal flora of livestock and reducing harmful bacteria It is possible to improve the intestinal environment of livestock, thereby preventing the occurrence of diseases and improving the productivity of livestock.

Claims (4)

  1.  カプリル酸、カプリン酸及びラウリン酸からなる群から選ばれる少なくとも1種類の脂肪酸又はその塩を含有する動物腸内有用菌増加剤。 An animal intestinal useful bacteria increasing agent containing at least one fatty acid selected from the group consisting of caprylic acid, capric acid and lauric acid or a salt thereof.
  2.  脂肪酸の塩がカルシウム塩である請求項1に記載の動物腸内有用菌増加剤。 The animal intestinal useful bacteria increasing agent according to claim 1, wherein the fatty acid salt is a calcium salt.
  3.  腸内有用菌がBifidobacterium 属に属する菌である請求項1又は2に記載の動物腸内有用菌増加剤。 3. The animal enteric useful bacteria increasing agent according to claim 1 or 2, wherein the enteric useful bacteria belong to the genus Bifidobacterium.
  4.  請求項1~3のいずれかに記載の動物腸内有用菌増加剤が0.1~2重量%配合された飼料を家畜に給与することを特徴とする家畜腸内環境改善方法。 A method for improving the intestinal environment of livestock, comprising feeding a livestock containing 0.1 to 2% by weight of the animal intestinal useful bacteria increasing agent according to any one of claims 1 to 3.
PCT/JP2015/053961 2015-02-13 2015-02-13 Agent for increasing useful bacteria in animal intestines, and method for improving intestinal environment in livestock in which said agent is used WO2016129100A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PCT/JP2015/053961 WO2016129100A1 (en) 2015-02-13 2015-02-13 Agent for increasing useful bacteria in animal intestines, and method for improving intestinal environment in livestock in which said agent is used
JP2016574594A JP6557686B2 (en) 2015-02-13 2015-02-13 Animal intestinal useful bacteria increasing agent and livestock intestinal environment improving method using the same
KR1020177018724A KR102376381B1 (en) 2015-02-13 2015-02-13 Agent for increasing useful bacteria in animal intestines, and method for improving intestinal environment in livestock in which said agent is used

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2015/053961 WO2016129100A1 (en) 2015-02-13 2015-02-13 Agent for increasing useful bacteria in animal intestines, and method for improving intestinal environment in livestock in which said agent is used

Publications (1)

Publication Number Publication Date
WO2016129100A1 true WO2016129100A1 (en) 2016-08-18

Family

ID=56614466

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2015/053961 WO2016129100A1 (en) 2015-02-13 2015-02-13 Agent for increasing useful bacteria in animal intestines, and method for improving intestinal environment in livestock in which said agent is used

Country Status (3)

Country Link
JP (1) JP6557686B2 (en)
KR (1) KR102376381B1 (en)
WO (1) WO2016129100A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109688832A (en) * 2016-09-02 2019-04-26 富士胶片株式会社 The growth of livestock feed or domestic animal replenishers, the growth promoter of Lactobacillus bacteria and Lactobacillus bacteria promotes method

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002518031A (en) * 1998-06-23 2002-06-25 ユニバーシティ オブ メリーランド Use of oils with high lauric acid content as animal feed
JP3480566B2 (en) * 1998-08-25 2003-12-22 日本水産株式会社 Natural bioactive substance effective for fish disease and fish feed containing it
JP2005270101A (en) * 2004-02-27 2005-10-06 Nippon Suisan Kaisha Ltd Feed for eel
JP2011062093A (en) * 2009-09-15 2011-03-31 Kaneka Corp Composition for food and/or feed
JP5259905B2 (en) * 2000-06-20 2013-08-07 エヌ・ブイ・ニュートリション・サイエンシス Medium chain fatty acids applicable as antibacterial agents
US20140037698A1 (en) * 2011-01-21 2014-02-06 Norel, S.A Additives for animal food

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2723961B2 (en) 1989-03-31 1998-03-09 花王株式会社 Veterinary milk substitute composition and breeding method
JP3203441B2 (en) 1992-11-19 2001-08-27 ミヨシ油脂株式会社 Livestock nutritional supplement
US20020094346A1 (en) * 1995-05-17 2002-07-18 M. D. Henry C. Lin Method and compositions for improving digestion and absorption in the small intestine
JPH10127232A (en) 1996-10-29 1998-05-19 Natl Fedelation Of Agricult Coop Assoc Substitute milk composition for juvenile livestock and raising of juvenile livestock
EP1059041A1 (en) * 1999-06-07 2000-12-13 Universiteit Gent The combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements
EP1314358A1 (en) * 2001-11-21 2003-05-28 N.V. Seghers Nutrition Sciences Antimicrobial composition for animals
JP2011505415A (en) * 2007-12-04 2011-02-24 ウエストゲート・バイオロジカル・リミテッド Blends of free fatty acids and their use
BE1019290A5 (en) * 2010-04-14 2012-05-08 Nutrition Sciences Nv Sa FOOD SUPPLEMENT INCLUDING OLIGOSACCHARIDES AND MEDIUM CHAIN FATTY ACIDS.
MX2012012416A (en) * 2010-04-26 2012-12-17 Enzymotec Ltd Methods and lipid compositions for promoting development of gut flora.

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002518031A (en) * 1998-06-23 2002-06-25 ユニバーシティ オブ メリーランド Use of oils with high lauric acid content as animal feed
JP3480566B2 (en) * 1998-08-25 2003-12-22 日本水産株式会社 Natural bioactive substance effective for fish disease and fish feed containing it
JP5259905B2 (en) * 2000-06-20 2013-08-07 エヌ・ブイ・ニュートリション・サイエンシス Medium chain fatty acids applicable as antibacterial agents
JP2005270101A (en) * 2004-02-27 2005-10-06 Nippon Suisan Kaisha Ltd Feed for eel
JP2011062093A (en) * 2009-09-15 2011-03-31 Kaneka Corp Composition for food and/or feed
US20140037698A1 (en) * 2011-01-21 2014-02-06 Norel, S.A Additives for animal food

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109688832A (en) * 2016-09-02 2019-04-26 富士胶片株式会社 The growth of livestock feed or domestic animal replenishers, the growth promoter of Lactobacillus bacteria and Lactobacillus bacteria promotes method

Also Published As

Publication number Publication date
JPWO2016129100A1 (en) 2017-11-24
KR20170117382A (en) 2017-10-23
JP6557686B2 (en) 2019-08-07
KR102376381B1 (en) 2022-03-17

Similar Documents

Publication Publication Date Title
US10834942B2 (en) Yeast and bacterial probiotics combinations and methods of use to improve swine production
US9986750B2 (en) Animal feed compositions and feed additives
WO2004037010A1 (en) A feed supplement and use thereof for elevating levels of essential fatty acids in livestock and products therefrom
JP2021528078A (en) Animal compositions and their use
CN104106737A (en) Powder-particle mixed type weaned piglet feed and preparation method thereof
RU2604501C1 (en) Method for feeding broiler chickens
CN109497322A (en) Improve the cat food of cat intestinal flora environment
KR100857771B1 (en) Compositions for addition to feed for fish comprising Bacillus polyfermenticus, Bacillus licheniformis and Saccharomyces serevisiae
Chimsung et al. Fermented golden apple snails as an alternative protein source in sex-reversed red tilapia (Oreochromis niloticus x O. mossambicus) diets
JP6557686B2 (en) Animal intestinal useful bacteria increasing agent and livestock intestinal environment improving method using the same
Raghebian et al. Probiotic Effect on Meat Quality and Carcass Parameters of Iranian Zandi lambs.
TWI663919B (en) Increasing agent for useful bacteria in animal intestines and livestock intestinal environment improvement method using the same
JP2006081530A (en) Oral administration composition for animal, and method for producing the same
Sheikh et al. Effect of probiotics mix supplementation on haemato-biochemical parameters and bacterial faecal shedding in Corriedale lambs fed paddy straw based complete feed
Kurchaeva et al. Influence of probiotic preparations on meat quality of farm animals
Živković et al. Garlic as alternative for antibiotics in diet for growing pigs
Singh et al. Effect of Aqua-Mos on growth performance and survivability of climbing perch (Anabas testudineus) during larval rearing
Mousa et al. EFFECT OF SPIRULINA AND PREBIOTIC (INMUNAIR 17.5®) ON NEWZEALAND WHITE RABBITS PERFORMANCE.
Alhidary et al. Effects of direct-fed microbial supplementation on growth performance and metabolic profile of newborn lambs weaned at different ages
WO2007097203A1 (en) Feed additive
Hamza Effect of Kemenzme Spirulina on Growing Rabbits Performance
Asafa et al. Response of pullet chickens to probiotic and antibiotic-supplemented diets
Onabanjo et al. Microbial population and blood profile of finisher broiler chickens fed diets supplemented with Crina poultry plus®.
Elakkad et al. EFFECT OF SPIRULINA LEVELS ON NEW-ZEALAND WHITE RABBITS PERFORMANCE
Gautam et al. EFFECTS OF DIETARY LIVE YEAST CULTURE (SACCHAROMYCES CEREVISIAE) ON FATTENING PERFORMANCE ON SOME BLOOD PARAMETERS OF BARBARI AND SIROHI GOAT KIDS.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15881975

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 20177018724

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2016574594

Country of ref document: JP

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 15881975

Country of ref document: EP

Kind code of ref document: A1